Logo image of AOMD.DE

ALSTOM (AOMD.DE) Stock Fundamental Analysis

FRA:AOMD - Deutsche Boerse Ag - FR0010220475 - Common Stock - Currency: EUR

19.51  -0.46 (-2.3%)

Fundamental Rating

3

Overall AOMD gets a fundamental rating of 3 out of 10. We evaluated AOMD against 109 industry peers in the Machinery industry. AOMD has a bad profitability rating. Also its financial health evaluation is rather negative. AOMD has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

AOMD had positive earnings in the past year.
AOMD had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AOMD reported negative net income in multiple years.
In multiple years AOMD reported negative operating cash flow during the last 5 years.
AOMD.DE Yearly Net Income VS EBIT VS OCF VS FCFAOMD.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B -2B 3B

1.2 Ratios

AOMD's Return On Assets of -0.76% is on the low side compared to the rest of the industry. AOMD is outperformed by 72.48% of its industry peers.
AOMD's Return On Equity of -2.47% is on the low side compared to the rest of the industry. AOMD is outperformed by 71.56% of its industry peers.
AOMD has a Return On Invested Capital of 2.59%. This is in the lower half of the industry: AOMD underperforms 69.72% of its industry peers.
Industry RankSector Rank
ROA -0.76%
ROE -2.47%
ROIC 2.59%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AOMD.DE Yearly ROA, ROE, ROICAOMD.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

1.3 Margins

In the last couple of years the Profit Margin of AOMD has declined.
AOMD has a Operating Margin of 3.16%. This is in the lower half of the industry: AOMD underperforms 67.89% of its industry peers.
In the last couple of years the Operating Margin of AOMD has declined.
AOMD has a worse Gross Margin (12.67%) than 90.83% of its industry peers.
AOMD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.16%
PM (TTM) N/A
GM 12.67%
OM growth 3Y69.79%
OM growth 5Y-11.95%
PM growth 3YN/A
PM growth 5Y-32.37%
GM growth 3Y3.78%
GM growth 5Y-6.9%
AOMD.DE Yearly Profit, Operating, Gross MarginsAOMD.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30 40

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AOMD is destroying value.
AOMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AOMD.DE Yearly Shares OutstandingAOMD.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
AOMD.DE Yearly Total Debt VS Total AssetsAOMD.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

AOMD has an Altman-Z score of 0.82. This is a bad value and indicates that AOMD is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AOMD (0.82) is worse than 69.72% of its industry peers.
AOMD has a debt to FCF ratio of 9.15. This is a negative value and a sign of low solvency as AOMD would need 9.15 years to pay back of all of its debts.
AOMD has a Debt to FCF ratio (9.15) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.32 indicates that AOMD is not too dependend on debt financing.
AOMD's Debt to Equity ratio of 0.32 is in line compared to the rest of the industry. AOMD outperforms 51.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 9.15
Altman-Z 0.82
ROIC/WACC0.37
WACC7.03%
AOMD.DE Yearly LT Debt VS Equity VS FCFAOMD.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 0.96 indicates that AOMD may have some problems paying its short term obligations.
AOMD has a Current ratio of 0.96. This is amonst the worse of the industry: AOMD underperforms 89.91% of its industry peers.
AOMD has a Quick Ratio of 0.96. This is a bad value and indicates that AOMD is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of AOMD (0.74) is worse than 75.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.74
AOMD.DE Yearly Current Assets VS Current LiabilitesAOMD.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 267.40% over the past year.
Measured over the past years, AOMD shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.26% on average per year.
AOMD shows a strong growth in Revenue. In the last year, the Revenue has grown by 54.74%.
The Revenue has been growing by 17.58% on average over the past years. This is quite good.
EPS 1Y (TTM)267.4%
EPS 3Y-25.02%
EPS 5Y-15.26%
EPS Q2Q%89.57%
Revenue 1Y (TTM)54.74%
Revenue growth 3Y26.26%
Revenue growth 5Y17.58%
Sales Q2Q%5.86%

3.2 Future

Based on estimates for the next years, AOMD will show a very strong growth in Earnings Per Share. The EPS will grow by 26.87% on average per year.
The Revenue is expected to grow by 4.26% on average over the next years.
EPS Next Y63.45%
EPS Next 2Y45.46%
EPS Next 3Y36.66%
EPS Next 5Y26.87%
Revenue Next Year5.43%
Revenue Next 2Y5.3%
Revenue Next 3Y4.86%
Revenue Next 5Y4.26%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AOMD.DE Yearly Revenue VS EstimatesAOMD.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
AOMD.DE Yearly EPS VS EstimatesAOMD.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 26.73 indicates a quite expensive valuation of AOMD.
The rest of the industry has a similar Price/Earnings ratio as AOMD.
Compared to an average S&P500 Price/Earnings ratio of 26.29, AOMD is valued at the same level.
Based on the Price/Forward Earnings ratio of 12.70, the valuation of AOMD can be described as correct.
AOMD's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of AOMD to the average of the S&P500 Index (22.17), we can say AOMD is valued slightly cheaper.
Industry RankSector Rank
PE 26.73
Fwd PE 12.7
AOMD.DE Price Earnings VS Forward Price EarningsAOMD.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AOMD indicates a somewhat cheap valuation: AOMD is cheaper than 61.47% of the companies listed in the same industry.
AOMD's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 23.17
EV/EBITDA 7.56
AOMD.DE Per share dataAOMD.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

AOMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AOMD's earnings are expected to grow with 36.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y45.46%
EPS Next 3Y36.66%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.03%, AOMD has a reasonable but not impressive dividend return.
The stock price of AOMD dropped by -20.20% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 2.75, AOMD pays a bit more dividend than its industry peers.
AOMD's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.03%

5.2 History

The dividend of AOMD decreases each year by -15.03%.
Dividend Growth(5Y)-15.03%
Div Incr Years0
Div Non Decr Years0
AOMD.DE Yearly Dividends per shareAOMD.DE Yearly Dividends per shareYearly Dividends per share 2017 2021 2022 2023 0.05 0.1 0.15 0.2

5.3 Sustainability

AOMD has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-7.39%
EPS Next 2Y45.46%
EPS Next 3Y36.66%
AOMD.DE Yearly Income VS Free CF VS DividendAOMD.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B -2B 3B

ALSTOM

FRA:AOMD (6/2/2025, 7:00:00 PM)

19.51

-0.46 (-2.3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)11-11 2025-11-11
Inst Owners59.23%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap9.01B
Analysts70.43
Price Target23.63 (21.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.03%
Yearly Dividend0.15
Dividend Growth(5Y)-15.03%
DP-7.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.01%
PT rev (3m)-0.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-0.73%
Valuation
Industry RankSector Rank
PE 26.73
Fwd PE 12.7
P/S 0.5
P/FCF 23.17
P/OCF 9.67
P/B 0.87
P/tB N/A
EV/EBITDA 7.56
EPS(TTM)0.73
EY3.74%
EPS(NY)1.54
Fwd EY7.88%
FCF(TTM)0.84
FCFY4.32%
OCF(TTM)2.02
OCFY10.34%
SpS38.86
BVpS22.5
TBVpS-1.74
PEG (NY)0.42
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.76%
ROE -2.47%
ROCE 3.68%
ROIC 2.59%
ROICexc 2.93%
ROICexgc 16.24%
OM 3.16%
PM (TTM) N/A
GM 12.67%
FCFM 2.17%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y69.79%
OM growth 5Y-11.95%
PM growth 3YN/A
PM growth 5Y-32.37%
GM growth 3Y3.78%
GM growth 5Y-6.9%
F-Score5
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 9.15
Debt/EBITDA 2.34
Cap/Depr 63.21%
Cap/Sales 3.02%
Interest Coverage 250
Cash Conversion 65.31%
Profit Quality N/A
Current Ratio 0.96
Quick Ratio 0.74
Altman-Z 0.82
F-Score5
WACC7.03%
ROIC/WACC0.37
Cap/Depr(3y)53.94%
Cap/Depr(5y)55.69%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)267.4%
EPS 3Y-25.02%
EPS 5Y-15.26%
EPS Q2Q%89.57%
EPS Next Y63.45%
EPS Next 2Y45.46%
EPS Next 3Y36.66%
EPS Next 5Y26.87%
Revenue 1Y (TTM)54.74%
Revenue growth 3Y26.26%
Revenue growth 5Y17.58%
Sales Q2Q%5.86%
Revenue Next Year5.43%
Revenue Next 2Y5.3%
Revenue Next 3Y4.86%
Revenue Next 5Y4.26%
EBIT growth 1Y11.59%
EBIT growth 3Y80.18%
EBIT growth 5Y3.59%
EBIT Next Year110.12%
EBIT Next 3Y36.12%
EBIT Next 5Y26.72%
FCF growth 1Y143.86%
FCF growth 3YN/A
FCF growth 5Y17.8%
OCF growth 1Y304.39%
OCF growth 3YN/A
OCF growth 5Y14.6%